Live Poll Results — Which revolutionary cancer treatment launched in 2017 became the first FDA-appro
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Launch Mastery: The Revolution of Targeted Therapies
In the evolving landscape of medical product launches, breakthrough therapies have transformed treatment paradigms and patient outcomes. This poll tests your knowledge about one of the most significant pharmaceutical product launches of the 2010s that revolutionized how we treat certain diseases by targeting specific genetic mutations rather than broad symptoms. Test your knowledge about this groundbreaking approach that changed medical practice!
Which revolutionary cancer treatment launched in 2017 became the first FDA-approved gene therapy in the United States, representing a paradigm shift in personalized medicine?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Kymriah (tisagenlecleucel) - the CAR-T therapy for acute lymphoblastic leukemia', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Keytruda (pembrolizumab) - the checkpoint inhibitor for multiple cancer types', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Spinraza (nusinersen) - the first treatment for spinal muscular atrophy', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Luxturna (voretigene neparvovec) - the gene therapy for inherited retinal disease', 'is_correct': False} | 0 | 0% |